1. [The development of severe methemoglobinemia in patients receiving "Almagel A"].
- Author
-
Starkov IuG, Kazennov VV, Vybornyĭ MI, Amerov DB, and Shumkina LV
- Subjects
- Aluminum Hydroxide administration & dosage, Aluminum Hydroxide therapeutic use, Benzocaine administration & dosage, Benzocaine therapeutic use, Drug Combinations, Female, Humans, Magnesium Hydroxide administration & dosage, Magnesium Hydroxide therapeutic use, Methemoglobin analysis, Methemoglobinemia blood, Methemoglobinemia therapy, Treatment Outcome, Aluminum Hydroxide adverse effects, Benzocaine adverse effects, Magnesium Hydroxide adverse effects, Methemoglobinemia chemically induced
- Abstract
This clinical case and the literature review show possible development of methemoglobinemia due to the use of local anesthetics, included in drugs for the gastrointestinal diseases treatment, in particular benzocaine, which is the methaemoglobin forming agent. These drugs are common and often taken by the patients themselves without any control. The aim of our paper is to draw the attention of physicians to the risk of the widely known drug administration which can be purchased without a prescription.
- Published
- 2014